Skip to main content
. Author manuscript; available in PMC: 2017 Apr 26.
Published in final edited form as: Neurourol Urodyn. 2016 Jul 26;36(4):1151–1154. doi: 10.1002/nau.23079

Table II.

Statistical analysis of patient variables by cohort.

Patient Variables by Cohort
Patient Variable Cardiovascular Manifestations (CV) n=53 (26.5%) Cardiac Risk Factors (CVR) n=44 (22%) Neurologic Etiology (N) n=81 (40.5%) Idiopathic Etiology (I) n=22 (11%) p value

Mean (SD)

Age 66.9 (12.3) 60.5 (15.3) 57.0 (14.4) 46.1 (16.4) <0.001

BMI 27.8 (5.4) 29.0 (7.5) 28.4 (7.1) 26.3 (5.5) 0.48

AUA-SS 22.0 (7.0) 17.7 (6.7) 22.9 (7.1) 21.7 (8.8) 0.06

n (%)

Compliance abnormality 3 (5.7) 5 (11.4) 5 (6.2) 2 (9.1) 0.67

Detrusor overactivty 8 (15.1) 6 (13.6) 11 (13.6) 3 (13.6) 1.00

Post-menopausal 48 (90.6) 35 (79.6) 50 (61.7) 8 (36.4) <0.001

Recurrent UTI 25 (47.2) 17 (38.7) 41 (50.6) 11 (50.0) 0.63

History of AUR 25 (47.2) 15 (34.1) 34 (41.9) 9 (40.9) 0.65

Presenting Symptomatology*:
    OAB (urgency, frequency, UUI) − (37.7) − (40.9) − (34.6) − (31.8) 0.97
    AUR − (28.3) − (27.3) − (25.9) − (27.3)
    Recurrent UTI − (30.2) − (22.7) − (32.1) − (31.8)
    Incomplete emptying, hesitancy − (3.8) − (9.1) − (7.4) − (9.1)

POP 12 6 12 2 0.49
*

Only % shown as patients may have initially presented with more than 1 symptom